Our participation CytoSmart has been designated by Microsoft as a promising AI and cloud computing scale-up

Our participation CytoSmart has been designated by Microsoft as a promising AI and cloud computing scale-up

Our participation CytoSmart has been designated by Microsoft as a promising AI and cloud computing scale-up

Amsterdam, 16th of January 2019 – Our participation CytoSmart has been designated by Microsoft as a promising AI and cloud computing scale-up.

Nine Dutch startups are joining Microsoft’s virtual ScaleUp program. The participating startups are developing solutions for sectors such as energy, healthcare, smart technologies, agriculture and finance. The program, designed to offer support for startups who are at a tipping point of becoming a scaleup, shows Microsoft’s commitment to expanding its startup activities with the promotion of AI solutions that have the potential to become innovation drivers for the Netherlands.

Please find the complete article HERE.

Holland Venture continues as Holland Capital

Holland Venture continues as Holland Capital

Holland Venture continues as Holland Capital

The experienced and hands-on investor in Healthcare and Technology

Amsterdam, 10 January 2019 – As of today, Holland Venture will continue as Holland Capital. The new name reflects the current positioning of the investor; with various funds, Holland Capital invests in venture, growth, and buy-out situations. She focuses on Dutch companies that are active in Healthcare and Technology.

Holland Capital has invested in more than 140 Dutch SMEs in a responsible and successful manner over the past 37 years. With a clear investment strategy, she is active in Healthcare and Technology. The experienced and hands-on investment team, consisting of 19 professionals, understand successful entrepreneurship. The investor focuses on companies with a strong management and significant growth potential, that respond successfully to market developments, and take a distinctive market position. She strives for an open, sustainable, and professional relationship with the management teams of her portfolio companies, with the common goal of achieving growth.

Holland Capital is supported by a broad network of successful entrepreneurs in the Healthcare and Technology sector. She has the ambition to realize 6 to 9 investments annually. For this, it currently has around EUR 100 million under management. The funds come from experienced entrepreneurs within the aforementioned focus areas, as well as from family offices, and institutional investors.

Ewout Prins, managing partner Holland Capital: “We are proud to launch our new name today. With our investment strategy, we focus on all Dutch companies with growth potential that are active in Healthcare and Technology markets. We invest both in young startups as well as in mature companies and offer a wide range of financing solutions in the field of venture capital, growth, and buy-out capital. Although this is widely known, we thought it was time to communicate this more clearly through our company name”.

Hubert Verbeek, managing partner Holland Capital: “This rebranding is more than a name change. It reflects the development that our organization goes through. Based on our track record, our investors’ confidence is growing, and the sizes of our funds are increasing. As a result, our organization is expanding, and we are investing in processes and our network. As such, we too are a growing company, making us even more capable of relating to the entrepreneurs in which we invest”.

HAVE A LOOK AT OUR VIDEO